Trial Profile
Retrospective chart review comparing the efficacy of TNF inhibitors against other biologics in patients with Adult Onset Still's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Anakinra (Primary) ; Infliximab (Primary) ; Tocilizumab (Primary) ; Etanercept; Interleukin 1 inhibitors; Interleukin 6 inhibitors
- Indications Adult-onset Still's disease
- Focus Therapeutic Use
- 09 Feb 2016 New trial record